These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epidermal cell presentation of tumor-associated antigens for induction of tolerance. Tan KC; Hosoi J; Grabbe S; Asahina A; Granstein RD J Immunol; 1994 Jul; 153(2):760-7. PubMed ID: 7912706 [TBL] [Abstract][Full Text] [Related]
4. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. Shimizu J; Suda T; Yoshioka T; Kosugi A; Fujiwara H; Hamaoka T J Immunol; 1989 Feb; 142(3):1053-9. PubMed ID: 2464022 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. Asahina A; Hosoi J; Beissert S; Stratigos A; Granstein RD J Immunol; 1995 Apr; 154(7):3056-61. PubMed ID: 7897198 [TBL] [Abstract][Full Text] [Related]
6. Regulation of tumor antigen presentation by urocanic acid. Beissert S; Mohammad T; Torri H; Lonati A; Yan Z; Morrison H; Granstein RD J Immunol; 1997 Jul; 159(1):92-6. PubMed ID: 9200443 [TBL] [Abstract][Full Text] [Related]
7. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. Hamaoka T; Shimizu J; Suda T; Fujiwara H Princess Takamatsu Symp; 1988; 19():265-75. PubMed ID: 3269360 [TBL] [Abstract][Full Text] [Related]
14. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts. Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850 [TBL] [Abstract][Full Text] [Related]
15. Dendritic epidermal T cells in ultraviolet-irradiated skin enhance skin tumor growth by inhibiting CD4+ T-cell-mediated immunity. Cavanagh LL; Halliday GM Cancer Res; 1996 Jun; 56(11):2607-15. PubMed ID: 8653705 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor gene transfer to dendritic cells or epidermal cells augments their antigen-presenting function including induction of anti-tumor immunity. Ozawa H; Ding W; Torii H; Hosoi J; Seiffert K; Campton K; Hackett NR; Topf N; Crystal RG; Granstein RD J Invest Dermatol; 1999 Dec; 113(6):999-1005. PubMed ID: 10594743 [TBL] [Abstract][Full Text] [Related]
17. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo. Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016 [TBL] [Abstract][Full Text] [Related]
18. Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA. Granstein RD; Ding W; Ozawa H J Invest Dermatol; 2000 Apr; 114(4):632-6. PubMed ID: 10733665 [TBL] [Abstract][Full Text] [Related]